Dianthus Therapeutics, Inc. (DNTH)
USD 23.28
(-4.08%)
USD 23.28
(-4.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.82 Million | 6.41 Million | 1.47 Million | - | - | - |
| Cost of Revenue | 355 Thousand | 147 Thousand | 2.02 Million | 1.97 Million | 1.84 Million | 875 Thousand |
| Gross Profit | 2.47 Million | 6.27 Million | -544 Thousand | -1.97 Million | -1.84 Million | -875 Thousand |
| Operating Expenses | 51 Million | 36.12 Million | 14.56 Million | 76.72 Million | 81.12 Million | 59.08 Million |
| Selling, General and Administrative Expenses | 18.15 Million | 6.74 Million | 1.95 Million | 28.08 Million | 23.76 Million | 17.74 Million |
| Research and Development Expenses | 32.84 Million | 29.37 Million | 12.6 Million | 48.63 Million | 57.36 Million | 41.34 Million |
| Other Expenses | - | -52 Thousand | - | - | - | - |
| Cost and Expenses | 51 Million | 36.12 Million | 14.56 Million | 78.7 Million | 82.96 Million | 59.96 Million |
| Operating Income | -48.17 Million | -29.7 Million | -13.08 Million | -78.7 Million | -82.96 Million | -59.96 Million |
| Interest Expense | - | - | 3.55 Million | 3.76 Million | - | - |
| Income Tax Expense | - | -1.28 Million | -1.99 Million | 7.53 Million | 6.2 Million | 2.44 Million |
| Earnings before Tax | -43.55 Million | -28.47 Million | -13.1 Million | -74.93 Million | -76.76 Million | -57.51 Million |
| Net Income | -43.55 Million | -28.47 Million | -13.1 Million | -74.93 Million | -76.76 Million | -57.51 Million |
| Earnings Per Share Basic | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 |
| Earnings Per Share Diluted | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 |
| Weighted Average Shares Outstanding | 5.15 Million | 3.74 Million | 3.43 Million | 2.74 Million | 2.31 Million | 1.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.15 Million | 3.74 Million | 3.43 Million | 2.74 Million | 2.31 Million | 1.14 Million |
| Gross Margin | 0.87 | 0.98 | -0.37 | - | - | - |
| EBIT Margin | -17.05 | -4.63 | -8.85 | - | - | - |
| Profit Margin | -15.41 | -4.44 | -8.88 | - | - | - |
| EBITDA | -48.17 Million | -29.55 Million | -13.08 Million | -72.95 Million | -74.92 Million | -56.64 Million |
| Earnings Before Tax Margin | -17.05 | -4.63 | -8.87 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.86 Million | 874 Thousand | 2.82 Million | 457 Thousand | 924 Thousand | 969 Thousand |
| Cost of Revenue | 111 Thousand | 107 Thousand | 355 Thousand | 103 Thousand | 19 Thousand | - |
| Gross Profit | 1.75 Million | 767 Thousand | 2.47 Million | 354 Thousand | 905 Thousand | 969 Thousand |
| Operating Expenses | 23.95 Million | 18.71 Million | 50.64 Million | 13.31 Million | 16.68 Million | 5.45 Million |
| Selling, General and Administrative Expenses | 5.88 Million | 5.64 Million | - | 4.52 Million | 8.72 Million | 5.31 Million |
| Research and Development Expenses | 18.07 Million | 13.07 Million | - | 8.78 Million | 7.96 Million | 139 Thousand |
| Other Expenses | -80 Thousand | -114 Thousand | -60 Thousand | -19 Thousand | -15 Thousand | -23 Thousand |
| Cost and Expenses | 24.06 Million | 18.71 Million | 51 Million | 13.41 Million | 16.68 Million | 5.45 Million |
| Operating Income | -22.2 Million | -17.84 Million | -48.17 Million | -12.95 Million | -15.75 Million | -5.45 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -107 Thousand | 187.1 Thousand | 848 Thousand | -1.02 Million | 179 Thousand |
| Earnings before Tax | -17.6 Million | -13.74 Million | -43.55 Million | -10.56 Million | -14.76 Million | -3.28 Million |
| Net Income | -17.6 Million | -13.74 Million | -43.55 Million | -10.56 Million | -14.76 Million | -3.28 Million |
| Earnings Per Share Basic | -0.51 | -0.54 | - | -0.71 | -3.78 | -0.87 |
| Earnings Per Share Diluted | -0.51 | -0.54 | - | -0.71 | -3.78 | -0.87 |
| Weighted Average Shares Outstanding | 34.22 Million | 25.66 Million | 5.15 Million | 14.81 Million | 3.9 Million | 3.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.22 Million | 25.66 Million | 5.15 Million | 14.81 Million | 3.9 Million | 3.79 Million |
| Gross Margin | 0.94 | 0.88 | 0.87 | 0.77 | 0.98 | 1.00 |
| EBIT Margin | -11.86 | -20.42 | - | -28.12 | -17.04 | -5.63 |
| Profit Margin | -9.45 | -15.73 | -15.41 | -23.11 | -15.98 | -3.39 |
| EBITDA | -22.09 Million | -17.84 Million | - | -12.85 Million | -15.74 Million | -5.45 Million |
| Earnings Before Tax Margin | -11.92 | -20.42 | -17.05 | -28.35 | -17.06 | -5.63 |
MGMNF
035000
BMW
OXBC
AE
FOOT-PREF